Understand the source comparison
Comparison: Post-Surgical Peptide Options
BPC-157 Upregulates VEGF and PDGF receptors for angiogenesis and collagen deposition Tendon repair, ligament reconstruction, orthopaedic surgery 250–500 mcg 1–2× daily Subcutaneous near wound site Days 1–21 post-surgery Strongest evidence for tendon-to-bone he
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- BPC-157
- Upregulates VEGF and PDGF receptors for angiogenesis and collagen deposition
- Tendon repair, ligament reconstruction, orthopaedic surgery
- 250–500 mcg 1–2× daily
- Subcutaneous near wound site
- Days 1–21 post-surgery
- Strongest evidence for tendon-to-bone healing and vascular recovery
- TB-500
- Promotes actin upregulation and cell migration; downregulates TNF-alpha
- Muscle tears, myocardial tissue, reducing fibrosis
- 2–5 mg twice weekly
- Subcutaneous (systemic)
- Weeks 1–8 post-surgery
- Best for preventing excessive scar tissue formation
- GHK-Cu
- Stimulates collagen I/III synthesis; activates MMPs for matrix remodelling
- Cosmetic surgery, skin incisions, scar reduction
- 1–3 mg daily
- Subcutaneous or topical
- Weeks 3–12 post-surgery
- Optimal for remodelling phase and long-term scar appearance
- IGF-1 LR3
- Enhances satellite cell proliferation and muscle protein synthesis
- Muscle-wasting prevention post-surgery
- 40–80 mcg daily
- Subcutaneous
- Weeks 2–6 post-surgery
- Secondary option for muscle preservation during immobilisation
- Sermorelin
- Stimulates endogenous GH release for systemic recovery
- General recovery support, metabolic maintenance
- 200–500 mcg before bed
- Ongoing post-surgery
- Least targeted but supports overall anabolic environment